We used 5,6-dichloro-1--D-ribofuranosylbenzimidazole (DBB), a selective and reversible inhibitor of mRNA production; io investigate the regulation of the pathway leading-to resistance to viruses in cells treated with interferon (IF). DRB The fact that the protection against viruses conferred upon cells by exposure to homologous interferon (IF) depends upon new mRNA synthesis was inferred from experiments in which actinomycin D was found to abolish the antiviral response when it was administered at the same time as the interferon (1, 2). As the time between treatment with IF and the addition of actinomycin was extended, so that longer periods of mRNA synthesis were permitted, the antiviral response reappeared and increased, until after several hours of delay in administering actinomycin, the drug no longer blocked establishment of the antiviral state (3, 4). It was deduced that the amount of protection from viral infection is proportional to the amount of IF-dependent mRNAs made and that synthesis of a protective quantity of such mRNAs is achieved by the time that actinomycin treatment no longer prevents resistance to viruses. Experiments with enucleated cells supported these findings (5, 6), as have recent studies of enzymes that inhibit mRNA translation (7-9). They include oligoisoadenylate synthetase and eukaryotic initiation factor 2 (eIF-2) protein kinase. These enzymes, and also a 2',5'-phosphodiesterase, have recently been isolated from IF-treated cells (10-13), as has an associated mRNA (12 
The fact that the protection against viruses conferred upon cells by exposure to homologous interferon (IF) depends upon new mRNA synthesis was inferred from experiments in which actinomycin D was found to abolish the antiviral response when it was administered at the same time as the interferon (1, 2) . As the time between treatment with IF and the addition of actinomycin was extended, so that longer periods of mRNA synthesis were permitted, the antiviral response reappeared and increased, until after several hours of delay in administering actinomycin, the drug no longer blocked establishment of the antiviral state (3, 4) . It was deduced that the amount of protection from viral infection is proportional to the amount of IF-dependent mRNAs made and that synthesis of a protective quantity of such mRNAs is achieved by the time that actinomycin treatment no longer prevents resistance to viruses. Experiments with enucleated cells supported these findings (5, 6) , as have recent studies of enzymes that inhibit mRNA translation (7) (8) (9) . They include oligoisoadenylate synthetase and eukaryotic initiation factor 2 (eIF-2) protein kinase. These enzymes, and also a 2',5'-phosphodiesterase, have recently been isolated from IF-treated cells (10) (11) (12) (13) , as has an associated mRNA (12) . The enzymes display IF dose dependence similar to that shown for development of resistance to viruses (13) , and the induction of the isolated IF-dependent proteins is blocked by exposure of the cells to actinomycin early after IF treatment (12) (13) (14) .
The experiments reported here had a different aim from
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "ad- (15) (16) (17) . Inhibition of mRNA synthesis imposed by DRB is rapid and the inhibition is promptly reversed after removal of the DRB by medium change (18) . Recent studies indicate that DRB permits uninterrupted initiation of transcription but promotes premature termination of nucleotide chains (19, 20) . It has only a minor effect on protein synthesis when cells are treated for several hours (15, 16, 18 35 -mm plates were exposed to 2 ml of either serum-free BME (control) or of' 1(X) PM DRB in serum-free BME. They were incubated at 37'C and the medium was removed from the plates either 1 hr or 5 hr thereafter. The medium was then replaced with either control (after washing four times) or DRB-containing serum-free BME and [:3H]uridine (specific activity 27 Ci/mmol) was added to a final concentration of 2.5 PCi/ml. Acidprecipitable cpm/Pg of protein were then determined in duplicate by the method described by Tamm 35 -mm plates were treated with DRB for 1 hr, then washed three times with BME/2% FCS (0); were untreated (0); or were treated with DRB for the duration of the experiment (A&). They were exposed to 5 X 106 PFU of VSV in 0.1 ml for 1 hr, washed three times with BME/2% FCS, and incubated in the same medium. At intervals plates were frozen and thawed and VSV output was assayed by plaque titration.
replication but also a slower decay of virus resistance revealed by DRB in cells treated with high concentrations of purified IF compared with cells exposed to 2048 units/ml of IF (Fig. 3) . The decay curve for 23,000 units/ml of MIF was approximately the same as that for 230,000 units/ml, suggesting that 23,000 units/ml of MIF induced a maximal mRNA response. Although the crude 2048-units/ml MIF used in this experiment was a different sample from the samples employed in the prior experiments (Fig. 2) (26) and that its spontaneous elution (24, 27) intervals and replaced (after wash) with BME/2% FCS. Cells were then incubated at 370C for 18-20 hr to allow development of antiviral activity, inoculated with 10o PFU of VSV, and incubated again for 24 hr. Supernatant fluids from triplicate coverslips were assayed for VSV output. The output of coverslips treated with DRB for 5 hr but not exposed to an MIF pulse is labeled "DRB 5 hr; removed." It closely approximated the output of coverslips treated with neither DRB nor MIF (not shown). The output of coverslips treated only with an MIF pulse (not shown) approximated the plotted output of those coverslips treated with both DRB and MIF from which DRB was removed at time zero, the end of the MIF pulse. Also plotted is the output of coverslips exposed to DRB for 5 hr before being treated with MIF for 1 hr and anti-MIF antibody for 15 min. The DRB was then removed by washing, as the label indicates, and further incubation and assay for VSV output were carried out as described above.
tance has recently been validated by the detection or isolation of mRNAs (12) and proteins (11) (12) (13) (14) from IF-treated cells.
Several proteins have, been identified. Two are doublestranded-RNA-dependent enzymes. The first, oligoisoadenylate synthetase, catalyzes the synthesis of pppA(2'p5'A)n, in which n is 2 to 5 (10). The trimer pppA2'p5'A2'p5'A is predominant. These oligoisoadenylate products activate a ribonuclease, already present in untreated cells, that degrades mRNA (30) (31) (32) (33) (34) . The second enzyme is a specific protein kinase that phosphorylates both a 67,000 Mr protein and the small subunit of eIF-2, inactivating the latter and thus preventing mRNA translation units/ml; *, purified MIF at 230,000 units/ml. Procedures and controls were those described for Fig. 2 . VSV outputs of controls, which closely resembled those presented in Fig. 2 , are not plotted. The sample of crude MIF containing 2048 units/ml was different from the samples used in the experiments shown in Fig. 2. (7-9, 13, 31). Both enzymes exhibit IF dose dependence paralleling that for the appearance of resistance to viruses (13) .
The action of these double-stranded-RNA-dependent enzymes might be regulated by two other enzymes also found in IF-treated cells (13) 24 hr triggers quick cessation of IF synthesis (39) ; hence the cells must remain committed for 24 hr to the synthesis of a mRNA that regulates IF production.
Our data indicate that there is also a mechanism that regulates the ultimate manifestation of virus resistance of IF-dependent mRNAs for antiviral proteins. The step at which regulation takes place has not been identified. Whether the mechanism is shutoff of mRNA transcription degradation or destruction of the mRNAs, restriction of enzyme action, lysis of intermediates such as oligoisoadenylate (perhaps by 2'-phosphodiesterase) or phosphorylated eIF-2 (perhaps by phosphoprotein phosphatase), or whether (as is likely) different mechanisms operate for the different antiviral pathways that apparently exist is unknown. It appears, however, that after an IF pulse the cell is committed for only a few hours to the full expression of the mRNAs that code for antiviral effector proteins.
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